Syantra, Inc., a precision biotechnology company revolutionizing cancer detection and treatment, proudly announces the appointment of Holly Smithson to its Board of Directors.
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback